Cargando…
Exploring the Mechanism of Indigo Naturalis in the Treatment of Ulcerative Colitis Based on TLR4/MyD88/NF-κB Signaling Pathway and Gut Microbiota
Background: Clinical trials have proven that indigo naturalis is a candidate drug for treating ulcerative colitis (UC), but its therapeutic mechanism is still unclear. Purpose: This study aimed to evaluate the protective effect and mechanism of indigo naturalis to treat mice with dextran sulfate sod...
Autores principales: | Yang, Qi-yue, Ma, Le-le, Zhang, Chen, Lin, Jun-zhi, Han, Li, He, Ya-nan, Xie, Chun-guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339204/ https://www.ncbi.nlm.nih.gov/pubmed/34366843 http://dx.doi.org/10.3389/fphar.2021.674416 |
Ejemplares similares
-
Treatment-refractory ulcerative colitis responsive to indigo naturalis
por: Saiki, Julie P, et al.
Publicado: (2021) -
Efficacy of Indigo Naturalis Therapy for Ulcerative Colitis: A Case Series
por: Urushikubo, Jun, et al.
Publicado: (2019) -
Ischemic colitis induced by indigo naturalis in a patient with ulcerative colitis: a case report
por: Cho, Byungha, et al.
Publicado: (2020) -
Indigo Naturalis Alleviates Dextran Sulfate Sodium-Induced Colitis in Rats via Altering Gut Microbiota
por: Sun, Zhongmei, et al.
Publicado: (2020) -
Jatrorrhizine Alleviates DSS-Induced Ulcerative Colitis by Regulating the Intestinal Barrier Function and Inhibiting TLR4/MyD88/NF-κB Signaling Pathway
por: Niu, Shengqi, et al.
Publicado: (2022)